GlassScriptPhysician profile
Robert D Hicks
NPI 1710969373
$4,704.64
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,390 · 2022: $1,932 · 2023: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $546.25 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $545.32 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $519.72 | 2021-2023 | Xarelto |
| Gilead Sciences, INC. | $437.63 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.13 | 2021-2023 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $293.42 | 2021-2023 | Fasenra, Lokelma |
| Pfizer INC. | $282.39 | 2021-2023 | |
| Boston Scientific Corporation | $275.49 | 2021-2023 | Spyglass Discover, Watchman Access System |
| Alnylam Pharmaceuticals INC. | $252.86 | 2022-2023 | Givlaari |
| Paratek Pharmaceuticals, INC. | $220.28 | 2021-2023 | Nuzyra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.14 | 2022-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $128.48 | 2021-2023 | Verquvo, Zerbaxa, Dificid |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.07 | 2021-2023 | Lifevest |
| Electromed, INC. | $115.84 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $115.45 | 2021-2023 | Ultomiris |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $58.34 | 2021-2022 | |
| Insmed, INC. | $47.24 | 2022 | |
| Melinta Therapeutics, LLC | $34.76 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.72 | 2021 | |
| Inari Medical, INC. | $28.06 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioxcel Therapeutics, INC. | $23.89 | 2023 | Igalmi |
| Cmp Pharma, INC. | $23.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.